TCON News and Press, TRACON Pharmaceuticals Inc. From 11/03/20

SAN DIEGO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform t...

The FDA has granted Orphan Drug designation to TRACON Pharmaceuticals' (TCON) TRC102 for the treatment of patients with malignant glioma, including glioblastoma ((GBM)).Among the benefits of Orphan Drug status in the U.S. is a seven-year period of market exclusivity for the indication, if app...

SAN DIEGO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform t...

TRACON Pharmaceuticals ([[TCON]] -13.3%) highlighted updated clinical data from the pivotal trial of envafolimab in MSI-H/dMMR cancer patients that were presented by the corporate partners, 3D Medicines and Alphamab Oncology. Duration of response was ≥12 months in 75% of patients ...

SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform ...

Strongbridge Biopharma (NASDAQ: SBBP )   -16%  after pricing $25M share offering. More news on: Strongbridge Biopharma plc, NuCana plc, Dave & Buster's Entertainment, Inc., Stocks on the move, , Read more ...

SAN DIEGO, Sept. 10, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . Stocks avoided back-to-back blowout losses Friday but couldn't quite close out the week with a gain, as a late-afternoon rally fell shor...

Do You Agree With Analysts’ Ratings On These Penny Stocks? Do you need penny stocks to have good analysts rating in order to buy them? While some rely on them when it comes to investing, the day-to-day trends usually aren’t reflective of analyst opinions. What I mean by this is...

SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform...